H. A. Abella | Authors

C-11 choline PET/CT boosts early prostate ca detection

November 17, 2009

Findings of a study by researchers in Italy suggest C-11 choline PET/CT could diagnose prostate cancer recurrence sooner than transrectal ultrasound, CT, MRI, or bone scintigraphy in patients who have undergone radical prostatectomy.

Mistrust, costs reduce breast cancer screening among minorities

June 19, 2009

Negative perceptions and tough economic times keep women away from screening programs, but self-examination still highly rated.

New ultrasound strategy helps pinpoint prostate tumors

June 19, 2009

A new technique, ultrasonic tissue-type imaging, could revolutionize the detection and treatment of prostate cancer, according to Ernest J. Feleppa, PhD, research director of the Frederic L. Lizzi Center for Biomedical Engineering at the Riverside Research Institute in New York. “The method seems to be capable of distinguishing cancerous from noncancerous tissue in the prostate,” Dr. Feleppa said

Minority groups protest CMS’ rejection of VC screening

April 24, 2009

Members of the Congressional Black Caucus have joined the ranks of virtual colonoscopy (VC or CT colonography [CTC]) advocates to pressure the Centers for Medicare and Medicaid Services to reverse a proposal to deny reimbursement for VC screening. Proponents argue that the policy could widen existing colon cancer screening inequalities.

Medicare approves coverage of FDG-PET scans for 11 cancers

April 23, 2009

The Centers for Medicare and Medicaid Services has opened a new chapter in the practice of PET with the announcement for a national Medicare payment policy that expands coverage of PET scans in the initial treatment strategy of most solid cancers and for myelo

Functional MRI boosts early staging of cervical cancer

March 23, 2009

Diffusion-weighted MRI added to standard T2-weighted scans can help spot cervical cancer in its early stages. A preliminary study from the Institute of Cancer Research in London determined that DWI can spot tumors missed by T2 imaging and bolster management options for women who wish to preserve reproductive organs.

Standardized chemoembolization boosts HCC survival

December 01, 2008

CHICAGO-Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes.

Panel pans FDG-PET for new Medicare oncology coverage

September 02, 2008

A Centers for Medicare and Medicaid Services advisory panel has found that most available clinical data for nine conditionally approved cancer indications of FDG-PET, evaluated by the National Oncologic PET Registry (NOPR) and a separate Canadian study, are too ambivalent to support Medicare coverage.

Sen. Kennedy's brain tumor puts spotlight on new treatment

September 02, 2008

News of Sen. Edward Kennedy’s diagnosis with a malignant glioma shocked the nation. It has also raised awareness about the grim prognosis associated with this type of brain tumor. A new study conducted by the American College of Radiology’s Radiation Therapy Oncology Group (RTOG) could bring hope to glioma patients.

MRI breast ca staging provided benefits, shortcomings

September 01, 2008

A meta-analysis by Australian and European researchers indicates that MR staging identifies additional disease in nearly one of five women previously diagnosed with breast cancer. It also suggests that women may undergo more extensive surgeries than originally planned because of false-positive MR findings.